Lexicon Pharmaceuticals
LXRX
#7142
Rank
HK$3.96 B
Marketcap
HK$10.90
Share price
-1.41%
Change (1 day)
115.47%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2025 (TTM): -HK$0.54 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are HK$70.86 Million. In 2024 the company made an earning of -HK$1.57 Billion a decrease over its 2023 earnings that were of -HK$1.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.54 Billion-65.85%
2024 -HK$1.57 Billion13.15%
2023 -HK$1.38 Billion73.74%
2022 -HK$0.8 Billion16.16%
2021 -HK$0.69 Billion49.82%
2020 -HK$0.46 Billion-147.19%
2019 HK$0.96 B-203.42%
2018 -HK$0.94 Billion-15.31%
2017 -HK$1.11 Billion0.2%
2016 -HK$1.11 Billion2920.7%
2015 -HK$36.45 Million-95.33%
2014 -HK$0.79 Billion-3.61%
2013 -HK$0.82 Billion-5.52%
2012 -HK$0.86 Billion-4.17%
2011 -HK$0.9 Billion15.5%
2010 -HK$0.78 Billion8.36%
2009 -HK$0.72 Billion-4.81%
2008 -HK$0.76 Billion28.79%
2007 -HK$0.59 Billion35.71%
2006 -HK$0.43 Billion52.91%
2005 -HK$0.29 Billion-23.89%
2004 -HK$0.37 Billion-24.19%
2003 -HK$0.49 Billion-0.48%
2002 -HK$0.49 Billion44.12%
2001 -HK$0.34 Billion23.01%
2000 -HK$0.28 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-HK$73.87 Million-86.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$40.05 B-7,602.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-HK$4.04 Billion 656.31%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$5.28 B-1,090.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$55.23 B-10,447.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-HK$0.22 Billion-59.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$7.74 B-1,550.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$0.51 B-197.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-HK$0.19 Billion-66.11%๐Ÿ‡บ๐Ÿ‡ธ USA